Northern Institute for Cancer Research

Staff Profile

Dr Jason Gill

Reader in Molecular Therapeutics


Jason Gill is a Reader in Molecular Therapeutics in the School of Pharmacy and the Northern Institute of Cancer Research at Newcastle University.

He gained his PhD in the field of Molecular Toxicology from the University of Manchester, a MRC-case studentship with Zeneca Central Toxicology Laboratories in Macclesfield (subsequently Astrazeneca). After a postdoctoral fellowship at the Cancer Research UK Clinical Centre in Leeds evaluating cellular and molecular biology of human Bladder Cancer. He was appointed to the University of Bradford as a lecturer in Molecular Pathology and was later promoted to a Senior Lectureship in Molecular Pharmacology. In 2012 he joined Durham University as a Reader/Associate Professor in Molecular Therapeutics and helped establish the new Division of Pharmacy within the School of Medicine, Pharmacy and Health. In August 2017 the School was transferred to Newcastle University resulting in the creation of the School of Pharmacy.

Jason’s research interests lie in the areas of preclinical safety assessment of cancer therapeutics and anticancer drug discovery and development, particularly identification and development of tumour-selective cancer therapeutics with reduced systemic toxicity